New frontiers in female contraception (and male condoms): 2012

Bibliography

• From the Centers for Disease Control and Prevention. Ten great public health achievements–United States, 1900-1999. JAMA 1999;281:1481
   PubMed Web of Science ®Google Scholar
• Stover J, Ross J. How increased contraceptive use has reduced maternal mortality. Matern Child Health J 2010;14:687-95
   PubMed Web of Science ®Google Scholar
• Cates W Jr. Family planning: the essential link to achieving all eight Millennium development goals. Contraception 2010;81:460-1
   PubMed Web of Science ®Google Scholar
• Hladik W, Stover J, Esiru G, The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One 2009;4:e7691
   Web of Science ®Google Scholar
• Nieschlag E. Clinical trials in male hormonal contraception. Contraception 2010;82:457-70
   PubMed Web of Science ®Google Scholar
• Kost K, Singh S, Vaughan B, Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 2008;77:10-21
   PubMed Web of Science ®Google Scholar
• Nettleman MD, Chung H, Brewer J, Reasons for unprotected intercourse: analysis of the PRAMS survey. Contraception 2007;75:361-6. Erratum in: Contraception 2007;76(5):413
   PubMed Web of Science ®Google Scholar
• Moos MK, Petersen R, Meadows K, Pregnant women's perspectives on intendedness of pregnancy. Womens Health Issues 1997;7:385-92
   PubMed Web of Science ®Google Scholar
• Grimes DA. Forgettable contraception. Contraception 2009;80:497-9
   PubMed Web of Science ®Google Scholar
• Lewis LN, Doherty DA, Hickey M, Skinner SR. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception 2010;81:421-6
   PubMed Web of Science ®Google Scholar
• Mansour D, Mommers E, Teede H, Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010;82:243-9
   PubMed Web of Science ®Google Scholar
• Gallo MF, Nanda K, Grimes DA, 20 µg versus > 20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2011(1):CD003989
   Google Scholar
• Sitruk-Ware R, Nath A. The use of newer progestins for contraception. Contraception 2010;82:410-17
   PubMed Web of Science ®Google Scholar
• Bitzer J. Pharmacological profile of estrogens in oral contraception. Minerva Ginecol 2011;63:299-304
   PubMedGoogle Scholar
• Grimes DA, Schulz KF. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol 2005;105:1114-18
   PubMed Web of Science ®Google Scholar
• Ruan X, Seeger H, Mueck AO. The pharmacology of dienogest. Maturitas 2012;71(4):337-44
   PubMed Web of Science ®Google Scholar
• Teichmann A. Pharmacology of estradiol valerate/dienogest. Climacteric 2003;6(Suppl 2):17-23
   PubMedGoogle Scholar
• Hoy SM, Scott LJ. Estradiol valerate/dienogest: in oral contraception. Drugs 2009;69:1635-46
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Makalova D, Parke S, Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009;80:436-44
   PubMed Web of Science ®Google Scholar
• Jensen JT, Parke S, Mellinger U, Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol 2011;117:777-87
   PubMed Web of Science ®Google Scholar
• Catherino WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55:239-46
   PubMed Web of Science ®Google Scholar
• Lal J. Clinical pharmacokinetics and interaction of centchroman–a mini review. Contraception 2010;81:275-80
   PubMed Web of Science ®Google Scholar
• Kerns J, Darney P. Vaginal ring contraception. Contraception 2011;83:107-15
   PubMed Web of Science ®Google Scholar
• Nath A, Sitruk-Ware R. Progesterone vaginal ring for contraceptive use during lactation. Contraception 2010;82:428-34
   PubMed Web of Science ®Google Scholar
• Grimes DA, Raymond EG, Scott Jones B. Emergency contraception over-the-counter: the medical and legal imperatives. Obstet Gynecol 2001;98:151-5
   PubMed Web of Science ®Google Scholar
• Hu X, Cheng L, Hua X, Glasier A. Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates: a randomized controlled trial. Contraception 2005;72:111-16
   PubMed Web of Science ®Google Scholar
• Glasier AF, Cameron ST, Fine PM, Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010;375:555-62
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Meng CX. Emergency contraception: potential role of ulipristal acetate. Int J Womens Health 2010;2:53-61
   PubMedGoogle Scholar
• Glasier A, Cameron ST, Blithe D, Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011;84:363-7
   PubMed Web of Science ®Google Scholar
• Massai MR, Forcelledo ML, Brache V, Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Hum Reprod 2007;22:434-9
   PubMed Web of Science ®Google Scholar
• Wu S, Godfrey EM, Wojdyla D, Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117:1205-10
   PubMed Web of Science ®Google Scholar
• Cecil M, Nelson AL, Trussell J, Hatcher R. If the condom doesn't fit, you must resize it. Contraception 2010;82:489-90
   PubMed Web of Science ®Google Scholar
• Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004;82:454-61
   PubMed Web of Science ®Google Scholar
• Beksinska M, Smit J, Joanis C, Female condom technology: new products and regulatory issues. Contraception 2011;83:316-21
   PubMed Web of Science ®Google Scholar
• Feldblum PJ, Kuyoh MA, Bwayo JJ, Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya. AIDS 2001;15:1037-44
   PubMed Web of Science ®Google Scholar
• Fontanet AL, Saba J, Chandelying V, Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. AIDS 1998;12:1851-9
   PubMed Web of Science ®Google Scholar
• Instructions for Using a Female Condom for Anal Sex. Available from: http://dchealth.dc.gov/doh/cwp/view,a,1371,q,602668.asp [Accessed 27 January 2012]
   Google Scholar
• Smita J, Neelam J, Rochelle DY, Comparative acceptability study of the Reality female condom and the version 4 of modified Reddy female condom in India. Contraception 2005;72:366-71
   PubMed Web of Science ®Google Scholar
• Schwartz JL, Barnhart K, Creinin MD, Comparative crossover study of the PATH Woman's Condom and the FC Female Condom. Contraception 2008;78:465-73
   PubMed Web of Science ®Google Scholar
• Joanis C, Beksinska M, Hart C, Three new female condoms: which do South-African women prefer? Contraception 2011;83:248-54
   PubMed Web of Science ®Google Scholar
• Coffey PS, Kilbourne-Brook M, Austin G, Short-term acceptability of the PATH Woman's Condom among couples at three sites. Contraception 2006;73:588-93
   PubMed Web of Science ®Google Scholar
• Sinai I, Cachan J. A Bridge for postpartum women to standard days method® II. efficacy study. Contraception 2012; Epub ahead of print
   Web of Science ®Google Scholar
• Smith RD. Contemporary hysteroscopic methods for female sterilization. Int J Gynaecol Obstet 2010;108:79-84
   PubMed Web of Science ®Google Scholar
• Ligt-Veneman NG, Tinga DJ, Kragt H, The efficacy of intratubal silicone in the Ovabloc hysteroscopic method of sterilization. Acta Obstet Gynecol Scand 1999;78:824-5
   PubMed Web of Science ®Google Scholar
• Zipper J, Kessel E. Quinacrine sterilization: a retrospective. Int J Gynaecol Obstet 2003;83(Suppl 2):S7-11
   PubMedGoogle Scholar
• Feldblum PJ, Wheeless A, Trujillo V, Pelvic surgery and hospitalization among Chilean women after nonsurgical sterilization with quinacrine pellets between 1977 and 1989. Contraception 2012; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Cancel AM, Dillberger JE, Kelly CM, A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats. Regul Toxicol Pharmacol 2010;56:156-65
   PubMed Web of Science ®Google Scholar
• Sokal DC, Vach TH, Nanda K, Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam. Epidemiology 2010;21:164-71
   PubMed Web of Science ®Google Scholar
• Sokal DC, Zipper J, King T. Transcervical quinacrine sterilization: clinical experience. Int J Gynaecol Obstet 1995;51:S57-69
   PubMed Web of Science ®Google Scholar
• de Magalhaes DR, de Carvalho Ferreira CR, Barbosa Magalhaes E, Quinacrine sterilization for human immunodeficiency virus-positive women. Fertil Steril 2009;92:108-15
   PubMed Web of Science ®Google Scholar
• Bart S Sr, Marr J, Diefenbach K, Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception 2012;85:42-50
   PubMed Web of Science ®Google Scholar
• Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 1995;40:355-60
   PubMed Web of Science ®Google Scholar
• Nelson AL, Westhoff C, Schnare SM. Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation. Obstet Gynecol 2008;112:782-7
   PubMed Web of Science ®Google Scholar
• Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstet Gynecol 2009;114:616-22
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Brown C, Pearlstein TB, Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 2005;106:492-501
   PubMed Web of Science ®Google Scholar
• Lindh I, Ellstrom AA, Milsom I. The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study. Hum Reprod 2012;27:676-82
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006;21:248-56
   PubMed Web of Science ®Google Scholar
• Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol 2012;119(3):519-26
   PubMed Web of Science ®Google Scholar
• Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;19:CD002126
   Google Scholar
• Fraser IS, Jensen J, Schaefers M, Normalization of blood loss in women with heavy menstrual bleeding treated withan oral contraceptive containing estradiol valerate/dienogest. Contraception 2012; [Epub ahead of print]
   Web of Science ®Google Scholar
• Tranexamic acid (Lysteda) for treatment of menorrhagia. Med Lett Drugs Ther 2010;52(1342):54-5
   PubMed Web of Science ®Google Scholar
• Kaneshiro B, Edelman A, Carlson NE, A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use. Contraception 2011; [Epub ahead of print]
   Web of Science ®Google Scholar
• Archer DF, Philput CB, Levine AS, Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users. Contraception 2008;78:106-12
   PubMed Web of Science ®Google Scholar
• Weisberg E, Hickey M, Palmer D, A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006;21:295-302
   PubMed Web of Science ®Google Scholar
• Mansour D, Bahamondes L, Critchley H, The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users. Contraception 2011;83:202-10
   PubMed Web of Science ®Google Scholar
• Hubacher D, Reyes V, Lillo S, Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195:1272-7
   PubMed Web of Science ®Google Scholar
• Allen RH, Bartz D, Grimes DA, Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2009;8:CD007373
   Google Scholar
• Dijkhuizen K, Dekkers OM, Holleboom CA, Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod 2011;26:323-9
   PubMed Web of Science ®Google Scholar
• Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75(5):344-54
   PubMed Web of Science ®Google Scholar
• Seeger JD, Loughlin J, Eng PM, Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110(3):587-93
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Nielsen LH, Skovlund CW, Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: danish cohort study, 2001 – 9. BMJ 2011;25:343
   Google Scholar
• van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009;13:339
   Google Scholar
• Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints. Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384 [Last accessed 16 February 2012]
   Google Scholar
• Scholes D, LaCroix AZ, Ichikawa LE, Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005;159:139-44
   PubMed Web of Science ®Google Scholar
• Cromer BA, Bonny AE, Stager M, Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril 2008;90:2060-7
   PubMed Web of Science ®Google Scholar
• Viola AS, Castro S, Marchi NM, Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate. Contraception 2011;84:122-7
   PubMed Web of Science ®Google Scholar
• Lopez LM, Grimes DA, Schulz KF, Curtis KM. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev 2011;6:CD006033
   Google Scholar
• Isley MM, Kaunitz AM. Update on hormonal contraception and bone density. Rev Endocr Metab Disord 2011;12:93-106
   PubMed Web of Science ®Google Scholar
• Nelson AL, Rezvan A. A pilot study of women's knowledge of pregnancy health risks: implications for contraception. Contraception 2012;85(1):78-82
   PubMed Web of Science ®Google Scholar
• Redmond G, Godwin AJ, Olson W, Lippman JS. Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence. Contraception 1999;60:81-5
   PubMed Web of Science ®Google Scholar
• Goldzieher JW, Moses LE, Averkin E, A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil Steril 1971;22:609-23
   PubMed Web of Science ®Google Scholar
• Coney P, Washenik K, Langley RG, Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 2001;63:297-302
   PubMed Web of Science ®Google Scholar
• O'Connell K, Davis AR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception 2007;75:299-304
   PubMed Web of Science ®Google Scholar
• Hahn RA. The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med 1997;26:607-11
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception 2011;83:5-9
   PubMed Web of Science ®Google Scholar
• Westhoff C, Heartwell S, Edwards S, Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecol 2007;109:1270-6
   PubMed Web of Science ®Google Scholar
• Schafer JE, Osborne LM, Davis AR, Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception 2006;73:488-92
   PubMed Web of Science ®Google Scholar
• Nelson AL, Katz T. Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA. Contraception 2007;75:84-7
   PubMed Web of Science ®Google Scholar
• Allen RH, Goldberg AB, Grimes DA. Expanding access to intrauterine contraception. Am J Obstet Gynecol 2009;201:456
   PubMed Web of Science ®Google Scholar
• Stewart FH, Harper CC, Ellertson CE, Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA 2001;285:2232-9
   PubMed Web of Science ®Google Scholar
• Henderson JT, Sawaya GF, Blum M, Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol 2010;116:1257-64
   PubMed Web of Science ®Google Scholar
• Foster DG, Parvataneni R, de Bocanegra HT, Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol 2006;108:1107-14
   PubMed Web of Science ®Google Scholar
• Nelson AL, Pietersz D, Nelson LE, Aguilera L. Documented short-term continuation rates for combined hormonal contraceptives in an indigent population with ready access to contraceptive supplies. Am J Obstet Gynecol 2007;196:599- e5-6
   PubMed Web of Science ®Google Scholar
• Foster DG, Hulett D, Bradsberry M, Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies. Obstet Gynecol 2011;117:566-72
   PubMed Web of Science ®Google Scholar
• Fox MC, Oat-Judge J, Severson K, Immediate placement of intrauterine devices after first and second trimester pregnancy termination. Contraception 2011;83:34-40
   PubMed Web of Science ®Google Scholar
• Grimes DA, Lopez LM, Schulz KF, Stanwood NL. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2010;16:CD001777
   Google Scholar
• Grimes DA, Lopez LM, Schulz KF, Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 2010;12:CD003036
   Google Scholar
• Hohmann HL, Reeves MF, Chen BA, Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial. Contraception 2012;85:240-5
   PubMed Web of Science ®Google Scholar
• Bednarek PH, Creinin MD, Reeves MF, Post-Aspiration IUD Randomization (PAIR) Study Trial Group. Immediate versus delayed IUD insertion after uterine aspiration. N Engl J Med 2011;364:2208-17
   PubMed Web of Science ®Google Scholar
• Brito MB, Ferriani RA, Quintana SM, Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 2009;80:519-26
   PubMed Web of Science ®Google Scholar
• Halderman LD, Nelson AL. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol 2002;186:1250-6
   PubMed Web of Science ®Google Scholar
• Postlethwaite D, Trussell J, Zoolakis A, A comparison of contraceptive procurement pre- and post-benefit change. Contraception 2007;76:360-5
   PubMed Web of Science ®Google Scholar
• Secura GM, Allsworth JE, Madden T, The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010;203:115- e1-7
   PubMed Web of Science ®Google Scholar
• Guazzelli CA, Barreiros FA, Barbosa R, Extended regimens of the vaginal contraceptive ring: cycle control. Contraception 2009;80:430-5
   PubMed Web of Science ®Google Scholar
• Downing D. Inviting the pharmacist: a model for improved reproductive care access. Contraception 2012;85:2-4
   PubMed Web of Science ®Google Scholar
• Krueger K, Akol A, Wamala P, Brunie A. Scaling up community provision of injectables through the public sector in Uganda. Stud Fam Plann 2011;42(2):117-24
   PubMed Web of Science ®Google Scholar
• Faundes D, Perdigao A, Faundes A, T-shaped IUDs accommodate in their position during the first 3 months after insertion. Contraception 2000;62:165-8
   PubMed Web of Science ®Google Scholar
• Braaten KP, Benson CB, Maurer R, Goldberg AB. Malpositioned intrauterine contraceptive devices: risk factors, outcomes, and future pregnancies. Obstet Gynecol 2011;118:1014-20
   PubMed Web of Science ®Google Scholar
• Westhoff C. IUDs and colonization or infection with Actinomyces. Contraception 2007;75:S48-50
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110
   PubMedGoogle Scholar
• Mansour D. Timely 'missed pill' information. J Fam Plann Reprod Health Care 2012;38:64
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012;97(3):616-22. e3
   PubMed Web of Science ®Google Scholar
• Wildemeersch D. New frameless and framed intrauterine devices and systems – an overview. Contraception 2007;75:S82-92
   PubMed Web of Science ®Google Scholar
• Wildemeersch D, Andrade A. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding. Gynecol Endocrinol 2010;26:383-9
   PubMed Web of Science ®Google Scholar
• Jick SS, Hagberg KW, Kaye JA. ORTHO EVRA and venous thromboembolism: an update. Contraception 2010;81(5):452-3
   PubMed Web of Science ®Google Scholar
• Dore DD, Norman H, Loughlin J, Seeger JD. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception 2010;81(5):408-13
   PubMed Web of Science ®Google Scholar
• Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 2007;109(2 Pt 1):339-46. Erratum in: Obstet Gynecol 2008;111(6):1449
   PubMed Web of Science ®Google Scholar
• Archer DF, Stanczyk FZ, Rubin A, Foegh M. Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial. Contraception 2011; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Agrawal SS, Pruthi JK. Development and evaluation of matrix type transdermal patch of ethinylestradiol and medroxyprogesterone acetate for anti-implantation activity in female Wistar rats. Contraception 2011;84:533-8
   PubMed Web of Science ®Google Scholar
• Maillard-Salin DG, Becourt P, Couarraze G. Physical evaluation of a new patch made of a progestomimetic in a silicone matrix. Int J Pharm 2000;199:29-38
   PubMed Web of Science ®Google Scholar
• von Hertzen H, Piaggio G, Ding J, WHO Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicenter randomised trial. Lancet 2002;360:1803-10
   PubMed Web of Science ®Google Scholar
• Wu S, Dong J, Cong J, Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial. Obstet Gynecol 2010;115:740-4
   PubMed Web of Science ®Google Scholar
• Sarkar NN. The state-of-the-art of emergency contraception with the cutting edge drug. Ger Med Sci 2011;9:Doc16
   PubMedGoogle Scholar
• Jesam C, Salvatierra AM, Schwartz JL, Croxatto HB. Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception. Hum Reprod 2010;25:368-73
   PubMed Web of Science ®Google Scholar
• Hester KE, Harper MJ, Duffy DM. Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception. Hum Reprod 2010;25(2):360-7
   PubMed Web of Science ®Google Scholar
• Tovey SJ, Bonell CP. Condoms: a wider range needed. BMJ 1993;307:987
   PubMed Web of Science ®Google Scholar
• Potter WD, de Villemeur M. Clinical breakage, slippage and acceptability of a new commercial polyurethane condom: a randomized, controlled study. Contraception 2003;68:39-45
   PubMed Web of Science ®Google Scholar
• Schwartz JL, Ballagh SA, Creinin MD, SILCS diaphragm: postcoital testing of a new single-size contraceptive device. Contraception 2008;78:237-44
   PubMed Web of Science ®Google Scholar
• Coffey PS, Kilbourne-Brook M, Beksinska M, Thongkrajai E. Short-term acceptability of a single-size diaphragm among couples in South Africa and Thailand. J Fam Plann Reprod Health Care 2008;34:233-6
   PubMed Web of Science ®Google Scholar
• Coffey PS, Kilbourne-Brook M, Brache V, Cochon L. Comparative acceptability of the SILCS and Ortho ALL-FLEX diaphragms among couples in the Dominican Republic. Contraception 2008;78:418-23
   PubMed Web of Science ®Google Scholar
• Frezieres RG, Walsh T, Kilbourne-Brook M, Coffey PS. Couples' acceptability of the SILCS diaphragm for microbicide delivery. Contraception 2012;85:99-107
   PubMed Web of Science ®Google Scholar
• Stafford MK, Ward H, Flanagan A, Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:327-31
   PubMedGoogle Scholar
• Van Damme L, Ramjee G, Alary M, COL-1492 Study Group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002;360:971-7
   PubMed Web of Science ®Google Scholar
• Catalone BJ, Ferguson ML, Miller SR, Prolonged exposure to the candidate microbicides C31G differentially reduces cellular sensitivity to agent re-exposure. Biomed Pharmacother 2005;59:460-8
   PubMed Web of Science ®Google Scholar
• Mauck CK, Creinin MD, Barnhart KT, A phase I comparative postcoital testing study of three concentrations of C31G. Contraception 2004;70:227-31
   PubMed Web of Science ®Google Scholar
• Burke AE, Barnhart K, Jensen JT, Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial. Obstet Gynecol 2010;116:1265-73
   PubMed Web of Science ®Google Scholar
• Barnhart KT, Rosenberg MJ, MacKay HT, Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. Obstet Gynecol 2007;110:577-86
   PubMed Web of Science ®Google Scholar
• Ramjee G, Kamali A, McCormack S. The last decade of microbicide clinical trials in Africa: from hypothesis to facts. AIDS 2010;24:S40-9
   PubMed Web of Science ®Google Scholar
• Das N, Chandran P, Chakraborty S. Potent spermicidal effect of oleanolic acid 3-beta-D-glucuronide, an active principle isolated from the plant Sesbania sesban Merrill. Contraception 2011;83:167-75
   PubMed Web of Science ®Google Scholar
• Singh KK, Parmar S, Tatke PA. Contraceptive efficacy and safety of HerbOshield™ vaginal gel in rats. Contraception 2012;85:122-7
   PubMed Web of Science ®Google Scholar
• Hadziomerovic D, Moeller KT, Licht P, The biphasic pattern of end-expiratory carbon dioxide pressure: a method for identification of the fertile phase of the menstrual cycle. Fertil Steril 2008;90:731-6
   PubMed Web of Science ®Google Scholar
• Bairagy NR, Mullick BC. Use of erythromycin for nonsurgical female sterilization in West Bengal, India: a study of 790 cases. Contraception 2004;69:47-9
   PubMed Web of Science ®Google Scholar
• Raymond EG, Ramchandani P, Shaunik A, Exploration of a new procedure for sterilization by intrauterine instillation of a methylcellulose gel. Contraception 2011;83:263-7
   PubMed Web of Science ®Google Scholar
• Wang LG, Qiu Y, Fan YJ, Reversible contraceptive effect of the oviduct plug with nickel-titanium shape memory alloy and silicone rubber in rabbits. Contraception 2011;83:373-7
   PubMed Web of Science ®Google Scholar
• Peluffo MC, Murphy MJ, Baughman ST, Systematic analysis of protease gene expression in the rhesus macaque ovulatory follicle: metalloproteinase involvement in follicle rupture. Endocrinology 2011;152:3963-74
   PubMed Web of Science ®Google Scholar
• Pattanayak SP, Mazumder PM. Effect of Dendrophthoe falcata (L.f.) Ettingsh on female reproductive system in Wistar rats: a focus on antifertility efficacy. Contraception 2009;80:314-20
   PubMed Web of Science ®Google Scholar
• Holash J, Davis S, Papadopoulos N, VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 2002;99:11393-8
   PubMed Web of Science ®Google Scholar
• Fraser HM, Morris KD, Wiegand SJ, Wilson H. Inhibition of vascular endothelial growth factor during the postovulatory period prevents pregnancy in the marmoset. Contraception 2010;82:572-8
   PubMed Web of Science ®Google Scholar
• Sun ZG, Shi HJ, Gu Z, A single intrauterine injection of the serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride reversibly inhibits embryo implantation in mice. Contraception 2007;76:250-5
   PubMed Web of Science ®Google Scholar
• Jiang YH, Shi Y, He YP, Serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF) inhibits the rat embryo implantation in vivo and interferes with cell adhesion in vitro. Contraception 2011;84:642-8
   PubMed Web of Science ®Google Scholar
• Killian G, Kreeger TJ, Rhyan J, Observations on the use of GonaCon in captive female elk (Cervus elaphus). J Wildl Dis 2009;45:184-8
   PubMed Web of Science ®Google Scholar
• Maruo T, Ohara N, Yoshida S, Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system. Contraception 2010;82:435-41
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366:409-20
   PubMed Web of Science ®Google Scholar
• Kelvin EA, Smith RA, Mantell JE, Stein ZA. Adding the female condom to the public health agenda on prevention of HIV and other sexually transmitted infections among men and women during anal intercourse. Am J Public Health 2009;99:985-7
   PubMed Web of Science ®Google Scholar
• Patai K, Szilagyi G, Noszal B, Szentmariay I. Local tissue effects of copper-containing intrauterine devices. Fertil Steril 2003;80:1281-3
   PubMed Web of Science ®Google Scholar
• Grillo CA, Reigosa MA, de Mele MA. Does over-exposure to copper ions released from metallic copper induce cytotoxic and genotoxic effects on mammalian cells? Contraception 2010;81:343-9
   PubMed Web of Science ®Google Scholar
• Hubacher D, Chen PL, Park S. Side effects from the copper IUD: do they decrease over time? Contraception 2009;79:356-62
   PubMed Web of Science ®Google Scholar
• Tang Y, Xia X, Wang Y, Xie C. Study on the mechanical properties of Cu/LDPE composite IUDs. Contraception 2011;83:255-62
   PubMed Web of Science ®Google Scholar
• Yang Z, Xie C, Xiang H, IDM release behavior and surface characteristics of the novel Cu/IDM/LDPE nanocomposite for intrauterine device. Colloids Surf B Biointerfaces 2009;69:276-80
   PubMed Web of Science ®Google Scholar
• Jinying L, Ying L, Xuan G, Investigation of the release behavior of cupric ion for three types of Cu-IUDs and indomethacin for medicated Cu-IUD in simulated uterine fluid. Contraception 2008;77(4):299-302. Erratum in: Contraception 2008;77:468
   PubMed Web of Science ®Google Scholar
• Zhao G, Li M, Zhu P, A preliminary morphometric study on the endometrium from patients treated with indomethacin-releasing copper intrauterine device. Hum Reprod 1997;12:1563-6
   PubMed Web of Science ®Google Scholar
• Liu Y, Guan F, Wang X, Development of a liquid chromatography-tandem mass spectrometry method for measuring plasma and uterine tissue levels of indomethacin in rabbits treated with indomethacin-medicated Cu-IUDs. Contraception 2011; [Epub ahead of print]
   Web of Science ®Google Scholar